GlassScriptPhysician profile
Joseph M Mets
NPI 1376960278
$9,652.12
in general payments reported to CMS, 2019-2025
11 companies · $583 in 2025
The $583 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,295 · 2020: $45.60 · 2021: $183 · 2022: $229 · 2023: $226 · 2024: $89.41 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,877.30 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $333.86 | 2025 | Signia |
| Lilly USA, LLC | $122.47 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Inari Medical, INC. | $105.13 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $60.94 | 2025 | Tisseel, Floseal |
| Inspiremd LTD | $41.14 | 2025 | Cguard Prime Carotid Stent System |
| Mauna Kea Technologies, INC. | $27.85 | 2024 | |
| Exact Sciences Corporation | $23.66 | 2024 | Cologuard Collection Kit |
| Aroa Biosurgery Incorporated | $23.04 | 2025 | |
| Stryker Corporation | $21.78 | 2025 | Flowtriever |
| Boston Scientific Corporation | $14.95 | 2025 | Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.